Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002

Claudia Allemani, Pamela Minicozzi, Franco Berrino, Esther Bastiaannet, Anna Gavin, Jaume Galceran, Alberto Ameijide, Sabine Siesling, Lucia Mangone, Eva Ardanaz, Guy Hédelin, Antonio Mateos, Andrea Micheli, Milena Sant

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Few studies have addressed longer-term survival for breast cancer in European women. We have made predictions of 10-year survival for European women diagnosed with breast cancer in 2000-2002. Data for 114,312 adult women (15-99 years) diagnosed with a first primary malignant cancer of the breast during 2000-2002 were collected in the EUROCARE-4 study from 24 population-based cancer registries in 14 European countries. We estimated relative survival at 1, 5, and 10 years after diagnosis for women who were alive at some point during 2000-2002, using the period approach. We also estimated 10-year survival conditional on survival to 1 and 5 years after diagnosis. Ten-year survival exceeded 70% in most regions, but was only 54% in Eastern Europe, with the highest value in Northern Europe (about 75%). Ten-year survival conditional on survival for 1 year was 2-6% higher than 10-year survival in all European regions, and geographic differences were smaller. Ten-year survival for women who survived at least 5 years was 88% overall, with the lowest figure in Eastern Europe (79%) and the highest in the UK (91%). Women aged 50-69 years had higher overall survival than older and younger women (79%). Six cancer registries had adequate information on stage at diagnosis; in these jurisdictions, 10-year survival was 89% for local, 62% for regional and 10% for metastatic disease. Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population-based survival, which provides vital information for improving breast cancer control. What's new? Policy-makers and health-care planners need accurate data on long-term survival to improve cancer control. This Europe-wide study of 10-year survival identified low survival in Eastern Europe for women with breast cancer in 2000-2002, and wide variation by age at diagnosis. Data on stage at diagnosis are crucial for meaningful comparison of population-based survival, and fundamental for improving breast cancer control, but our analyses confirmed that stage data are not collected routinely or consistently

Original languageEnglish
Pages (from-to)2404-2412
Number of pages9
JournalInternational Journal of Cancer
Volume132
Issue number10
DOIs
Publication statusPublished - May 15 2013

Fingerprint

Breast Neoplasms
Survival
Eastern Europe
Registries
Population
Neoplasms
Administrative Personnel
Delivery of Health Care

Keywords

  • breast cancer
  • EUROCARE
  • long-term survival
  • stage

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. / Allemani, Claudia; Minicozzi, Pamela; Berrino, Franco; Bastiaannet, Esther; Gavin, Anna; Galceran, Jaume; Ameijide, Alberto; Siesling, Sabine; Mangone, Lucia; Ardanaz, Eva; Hédelin, Guy; Mateos, Antonio; Micheli, Andrea; Sant, Milena.

In: International Journal of Cancer, Vol. 132, No. 10, 15.05.2013, p. 2404-2412.

Research output: Contribution to journalArticle

Allemani, C, Minicozzi, P, Berrino, F, Bastiaannet, E, Gavin, A, Galceran, J, Ameijide, A, Siesling, S, Mangone, L, Ardanaz, E, Hédelin, G, Mateos, A, Micheli, A & Sant, M 2013, 'Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002', International Journal of Cancer, vol. 132, no. 10, pp. 2404-2412. https://doi.org/10.1002/ijc.27895
Allemani C, Minicozzi P, Berrino F, Bastiaannet E, Gavin A, Galceran J et al. Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. International Journal of Cancer. 2013 May 15;132(10):2404-2412. https://doi.org/10.1002/ijc.27895
Allemani, Claudia ; Minicozzi, Pamela ; Berrino, Franco ; Bastiaannet, Esther ; Gavin, Anna ; Galceran, Jaume ; Ameijide, Alberto ; Siesling, Sabine ; Mangone, Lucia ; Ardanaz, Eva ; Hédelin, Guy ; Mateos, Antonio ; Micheli, Andrea ; Sant, Milena. / Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. In: International Journal of Cancer. 2013 ; Vol. 132, No. 10. pp. 2404-2412.
@article{b97162f5de02483b94f33d8bbc895c8b,
title = "Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002",
abstract = "Few studies have addressed longer-term survival for breast cancer in European women. We have made predictions of 10-year survival for European women diagnosed with breast cancer in 2000-2002. Data for 114,312 adult women (15-99 years) diagnosed with a first primary malignant cancer of the breast during 2000-2002 were collected in the EUROCARE-4 study from 24 population-based cancer registries in 14 European countries. We estimated relative survival at 1, 5, and 10 years after diagnosis for women who were alive at some point during 2000-2002, using the period approach. We also estimated 10-year survival conditional on survival to 1 and 5 years after diagnosis. Ten-year survival exceeded 70{\%} in most regions, but was only 54{\%} in Eastern Europe, with the highest value in Northern Europe (about 75{\%}). Ten-year survival conditional on survival for 1 year was 2-6{\%} higher than 10-year survival in all European regions, and geographic differences were smaller. Ten-year survival for women who survived at least 5 years was 88{\%} overall, with the lowest figure in Eastern Europe (79{\%}) and the highest in the UK (91{\%}). Women aged 50-69 years had higher overall survival than older and younger women (79{\%}). Six cancer registries had adequate information on stage at diagnosis; in these jurisdictions, 10-year survival was 89{\%} for local, 62{\%} for regional and 10{\%} for metastatic disease. Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population-based survival, which provides vital information for improving breast cancer control. What's new? Policy-makers and health-care planners need accurate data on long-term survival to improve cancer control. This Europe-wide study of 10-year survival identified low survival in Eastern Europe for women with breast cancer in 2000-2002, and wide variation by age at diagnosis. Data on stage at diagnosis are crucial for meaningful comparison of population-based survival, and fundamental for improving breast cancer control, but our analyses confirmed that stage data are not collected routinely or consistently",
keywords = "breast cancer, EUROCARE, long-term survival, stage",
author = "Claudia Allemani and Pamela Minicozzi and Franco Berrino and Esther Bastiaannet and Anna Gavin and Jaume Galceran and Alberto Ameijide and Sabine Siesling and Lucia Mangone and Eva Ardanaz and Guy H{\'e}delin and Antonio Mateos and Andrea Micheli and Milena Sant",
year = "2013",
month = "5",
day = "15",
doi = "10.1002/ijc.27895",
language = "English",
volume = "132",
pages = "2404--2412",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002

AU - Allemani, Claudia

AU - Minicozzi, Pamela

AU - Berrino, Franco

AU - Bastiaannet, Esther

AU - Gavin, Anna

AU - Galceran, Jaume

AU - Ameijide, Alberto

AU - Siesling, Sabine

AU - Mangone, Lucia

AU - Ardanaz, Eva

AU - Hédelin, Guy

AU - Mateos, Antonio

AU - Micheli, Andrea

AU - Sant, Milena

PY - 2013/5/15

Y1 - 2013/5/15

N2 - Few studies have addressed longer-term survival for breast cancer in European women. We have made predictions of 10-year survival for European women diagnosed with breast cancer in 2000-2002. Data for 114,312 adult women (15-99 years) diagnosed with a first primary malignant cancer of the breast during 2000-2002 were collected in the EUROCARE-4 study from 24 population-based cancer registries in 14 European countries. We estimated relative survival at 1, 5, and 10 years after diagnosis for women who were alive at some point during 2000-2002, using the period approach. We also estimated 10-year survival conditional on survival to 1 and 5 years after diagnosis. Ten-year survival exceeded 70% in most regions, but was only 54% in Eastern Europe, with the highest value in Northern Europe (about 75%). Ten-year survival conditional on survival for 1 year was 2-6% higher than 10-year survival in all European regions, and geographic differences were smaller. Ten-year survival for women who survived at least 5 years was 88% overall, with the lowest figure in Eastern Europe (79%) and the highest in the UK (91%). Women aged 50-69 years had higher overall survival than older and younger women (79%). Six cancer registries had adequate information on stage at diagnosis; in these jurisdictions, 10-year survival was 89% for local, 62% for regional and 10% for metastatic disease. Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population-based survival, which provides vital information for improving breast cancer control. What's new? Policy-makers and health-care planners need accurate data on long-term survival to improve cancer control. This Europe-wide study of 10-year survival identified low survival in Eastern Europe for women with breast cancer in 2000-2002, and wide variation by age at diagnosis. Data on stage at diagnosis are crucial for meaningful comparison of population-based survival, and fundamental for improving breast cancer control, but our analyses confirmed that stage data are not collected routinely or consistently

AB - Few studies have addressed longer-term survival for breast cancer in European women. We have made predictions of 10-year survival for European women diagnosed with breast cancer in 2000-2002. Data for 114,312 adult women (15-99 years) diagnosed with a first primary malignant cancer of the breast during 2000-2002 were collected in the EUROCARE-4 study from 24 population-based cancer registries in 14 European countries. We estimated relative survival at 1, 5, and 10 years after diagnosis for women who were alive at some point during 2000-2002, using the period approach. We also estimated 10-year survival conditional on survival to 1 and 5 years after diagnosis. Ten-year survival exceeded 70% in most regions, but was only 54% in Eastern Europe, with the highest value in Northern Europe (about 75%). Ten-year survival conditional on survival for 1 year was 2-6% higher than 10-year survival in all European regions, and geographic differences were smaller. Ten-year survival for women who survived at least 5 years was 88% overall, with the lowest figure in Eastern Europe (79%) and the highest in the UK (91%). Women aged 50-69 years had higher overall survival than older and younger women (79%). Six cancer registries had adequate information on stage at diagnosis; in these jurisdictions, 10-year survival was 89% for local, 62% for regional and 10% for metastatic disease. Data on stage are not collected routinely or consistently, yet these data are essential for meaningful comparison of population-based survival, which provides vital information for improving breast cancer control. What's new? Policy-makers and health-care planners need accurate data on long-term survival to improve cancer control. This Europe-wide study of 10-year survival identified low survival in Eastern Europe for women with breast cancer in 2000-2002, and wide variation by age at diagnosis. Data on stage at diagnosis are crucial for meaningful comparison of population-based survival, and fundamental for improving breast cancer control, but our analyses confirmed that stage data are not collected routinely or consistently

KW - breast cancer

KW - EUROCARE

KW - long-term survival

KW - stage

UR - http://www.scopus.com/inward/record.url?scp=84874931728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874931728&partnerID=8YFLogxK

U2 - 10.1002/ijc.27895

DO - 10.1002/ijc.27895

M3 - Article

C2 - 23047687

AN - SCOPUS:84874931728

VL - 132

SP - 2404

EP - 2412

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 10

ER -